{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:35Z","timestamp":1768003235450,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":98,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100374","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T10:34:59Z","timestamp":1618828499000},"page":"100374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis"],"prefix":"10.1016","volume":"27","author":[{"given":"NA","family":"Diez-Calzadilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Noguera Salv\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Soriano Sarri\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JM","family":"Mart\u00ednez-Jabaloyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2021.100374_bib0001","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100374_bib0002","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"10021","key":"10.1016\/j.ctarc.2021.100374_bib0003","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","article-title":"Renal cancer","volume":"387","author":"Capitanio","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100374_bib0004","first-page":"3954","article-title":"Treatment options for metastatic renal cell carcinoma: a review","volume":"15","author":"Athar","year":"2008","journal-title":"Can J Urol"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100374_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100374_bib0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"5112","key":"10.1016\/j.ctarc.2021.100374_bib0007","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100374_bib0008","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.eururo.2011.06.048","article-title":"Basic research in kidney cancer","volume":"60","author":"Oosterwijk","year":"2011","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.ctarc.2021.100374_bib0009","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000478-198210000-00007","article-title":"Prognostic significance of morphologic parameters in renal cell carcinoma","volume":"6","author":"Fuhrman","year":"1982","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100374_bib0010","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gnf056","article-title":"Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification","volume":"30","author":"Schouten","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100374_bib0011","doi-asserted-by":"crossref","first-page":"e33865","DOI":"10.1371\/journal.pone.0033865","article-title":"Evaluation of methods for the extraction and purification of DNA from the human microbiome","volume":"7","author":"Yuan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctarc.2021.100374_bib0012","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1038\/srep09465","article-title":"PI3K\u03b2 inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways","volume":"5","author":"Feng","year":"2015","journal-title":"Sci Rep."},{"issue":"20","key":"10.1016\/j.ctarc.2021.100374_bib0013","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/cncr.25279","article-title":"Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma","volume":"116","author":"La Rochelle","year":"2010","journal-title":"Cancer."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100374_bib0014","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/bjc.2014.420","article-title":"Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery","volume":"111","author":"El-Mokadem","year":"2014","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100374_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00313020410001671984","article-title":"Genetic changes of the E-cadherin and APC tumour suppressor genes in clear cell renal cell carcinoma","volume":"36","author":"Pe\u0107ina-SLaus","year":"2004","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100374_bib0016","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s001090050375","article-title":"Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas","volume":"77","author":"Pe\u0107ina-Slaus","year":"1999","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100374_bib0017","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000227697","article-title":"Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors","volume":"54","author":"Suzuki","year":"1997","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100374_bib0018","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cancergencyto.2005.03.015","article-title":"Smoking may cause genetic alterations at 5q22.2 approximately q23.1 in clear-cell renal cell carcinoma","volume":"163","author":"Korenaga","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100374_bib0019","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bjc.1995.189","article-title":"Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status","volume":"71","author":"McCann","year":"1995","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100374_bib0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cncr.24841","article-title":"p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?","volume":"116","author":"Noon","year":"2010","journal-title":"Cancer."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100374_bib0021","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.0.CO;2-D","article-title":"Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma","volume":"78","author":"Campbell","year":"1998","journal-title":"Int J Cancer."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100374_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102041","article-title":"Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma","volume":"9","author":"Sampson","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100374_bib0023","doi-asserted-by":"crossref","first-page":"e58396","DOI":"10.1371\/journal.pone.0058396","article-title":"Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100374_bib0024","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0888-7543(92)90126-D","article-title":"Genomic organization, chromosomal localization, and independent expression of human cyclin D genes","volume":"13","author":"Inaba","year":"1992","journal-title":"Genomics"},{"issue":"21","key":"10.1016\/j.ctarc.2021.100374_bib0025","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/onc.2009.89","article-title":"DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes","volume":"28","author":"Tanaka","year":"2009","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.ctarc.2021.100374_bib0026","article-title":"The silencing of CCND2 by promoter aberrant methylation in renal cell cancer and analysis of the correlation between CCND2 methylation status and clinical features","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100374_bib0027","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/ijms16011051","article-title":"Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma","volume":"16","author":"Xu","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.ctarc.2021.100374_bib0028","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cncr.28521","article-title":"Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma","volume":"120","author":"Joseph","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100374_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.10.014","article-title":"Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma","volume":"33","author":"Ho","year":"2015","journal-title":"Urol Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100374_bib0030","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3892\/ijo.2013.2124","article-title":"Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues","volume":"43","author":"Liu","year":"2013","journal-title":"Int J Oncol"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100374_bib0031","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctarc.2021.100374_bib0032","series-title":"Robbins & Cotran Pathologic Basis of Disease","article-title":"Molecular basis of cancer","author":"Kumar","year":"2009"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100374_bib0033","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejso.2012.10.004","article-title":"High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma","volume":"39","author":"Wu","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100374_bib0034","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/path.4592","article-title":"PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas","volume":"237","author":"Macher-Goeppinger","year":"2015","journal-title":"J Pathol"},{"issue":"15","key":"10.1016\/j.ctarc.2021.100374_bib0035","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-05-1128","article-title":"Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency","volume":"65","author":"Zanesi","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100374_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2011.08.012","article-title":"Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC)","volume":"31","author":"Singh","year":"2013","journal-title":"Urol Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100374_bib0037","doi-asserted-by":"crossref","first-page":"965","DOI":"10.5858\/2008-132-965-CSORET","article-title":"Cytogenetic studies of 24 renal epithelial tumors with von Hippel-Lindau and fragile histidine triad protein expression correlation.","volume":"132","author":"Gayrard","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100374_bib0038","first-page":"1323","article-title":"Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus","volume":"59","author":"Velickovic","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100374_bib0039","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/path.1062","article-title":"FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival","volume":"196","author":"Ramp","year":"2002","journal-title":"J Pathol"},{"issue":"4938","key":"10.1016\/j.ctarc.2021.100374_bib0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.2294591","article-title":"Identification of a chromosome 18q gene that is altered in colorectal cancers","volume":"247","author":"Fearon","year":"1990","journal-title":"Science."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100374_bib0041","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0022-5347(17)35760-9","article-title":"Tumor suppressor gene allelic loss in human renal cancers","volume":"150","author":"Brooks","year":"1993","journal-title":"J Urol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100374_bib0042","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1464-410X.2003.04730.x","article-title":"DCC protein expression in clear cell renal cell carcinoma","volume":"93","author":"Dekel","year":"2004","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100374_bib0043","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","article-title":"AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis","volume":"84","author":"Okuda","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2021.100374_bib0044","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/450621","article-title":"RNA sequencing reveals upregulation of RUNX1-RUNX1T1 gene signatures in clear cell renal cell carcinoma","volume":"2014","author":"Xiong","year":"2014","journal-title":"Biomed Res Int."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100374_bib0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.urology.2009.09.052","article-title":"Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials","volume":"75","author":"Zhou","year":"2010","journal-title":"Urology."},{"issue":"18","key":"10.1016\/j.ctarc.2021.100374_bib0046","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.ejca.2010.07.020","article-title":"Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment","volume":"46","author":"Tostain","year":"2010","journal-title":"Eur J Cancer."},{"issue":"30","key":"10.1016\/j.ctarc.2021.100374_bib0047","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1200\/JCO.2007.12.1087","article-title":"Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma","volume":"25","author":"Leibovich","year":"2007","journal-title":"J Clin Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:20:30Z","timestamp":1762842030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":47,"alternative-id":["S2468294221000721"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100374","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100374"}}